验证数据展示
经过测试的应用
Positive WB detected in | HT-29 cells |
Positive IHC detected in | human intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
KD/KO | See 2 publications below |
WB | See 2 publications below |
产品信息
16738-1-AP targets BAIAP2L2 in WB, IHC, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IHC, ELISA Application Description |
文献引用应用 | WB |
经测试反应性 | human |
文献引用反应性 | human, mouse |
免疫原 | BAIAP2L2 fusion protein Ag9904 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | BAI1-associated protein 2-like 2 |
别名 | UNQ9336/PRO34007, Planar intestinal- and kidney-specific BAR domain protein, Pinkbar, Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2, BAR/IMD domain-containing adapter protein 2-like 2 |
计算分子量 | 518 aa, 58 kDa |
观测分子量 | 57 kDa |
GenBank蛋白编号 | BC015619 |
基因名称 | BAIAP2L2 |
Gene ID (NCBI) | 80115 |
RRID | AB_2878309 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q6UXY1 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
Product Specific Protocols | |
---|---|
WB protocol for BAIAP2L2 antibody 16738-1-AP | Download protocol |
IHC protocol for BAIAP2L2 antibody 16738-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
J Cell Physiol BAIAP2L2 is required for the maintenance of mechanotransducing stereocilia of cochlear hair cells.
| ||
Biomed Pharmacother BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/β-catenin signaling pathways.
|